CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Q3 2025 Earnings Call Feb 18, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...

Q3 2025 Earnings Call Transcript February 18, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.39, ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Medtronic (MDT) beat estimates for profits in the last quarter thanks to strong demand for diabetes and heart ...

Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...